New Market Perspective
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

New Market Perspective

Politics

Trump picks Dr. Marty Makary as Food and Drug Administration commissioner

by admin November 23, 2024
November 23, 2024
Trump picks Dr. Marty Makary as Food and Drug Administration commissioner

President-elect Trump on Friday announced he is nominating Johns Hopkins School of Medicine professor Dr. Marty Makary for Food and Drug Administration (FDA) commissioner. 

‘I am very pleased to nominate Marty Makary MD, MPH, FACS, for FDA Commissioner,’ Trump said in a statement. ‘FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency.’ 

Makary’s nomination comes after Trump nominated Robert F. Kennedy, Jr. to lead the Department of Health and Human Services (HHS) to ‘Make America healthy again.’

Trump said Makary will ‘work under the leadership of Robert F. Kennedy Jr. to, among other things, properly evaluate harmful chemicals poisoning our Nation’s food supply and drugs and biologics being given to our Nation’s youth, so that we can finally address the Childhood Chronic Disease Epidemic.’ 

Trump in his statement added that Makary, who was a Fox News medical contributor, is also a ‘member of the prestigious National Academy of Medicine’ and ‘has devoted his career to improving Medical Quality and lowering Hospital and Drug Costs for all Americans. In addition, Dr. Makary is an accomplished Professor at the Johns Hopkins School of Medicine and Johns Hopkins Carey Business School, and a leading advocate for Healthcare Transparency. He has authored more than 300 scientific articles and three New York Times bestselling books on Healthcare.

Trump called Makary a ‘pioneer in the fields of Public Health, Cancer Care, and Surgery, and a tireless voice for vulnerable populations. He is the recipient of the Nobility in Science Award from the National Pancreas Foundation and numerous teaching awards. Dr. Makary currently leads the Evidence-Based Medicine and Public Policy Research Group at Johns Hopkins.’

He added, ‘I am confident that Dr. Makary, having dedicated his career to High-Quality, Lower-Cost Care, will restore FDA to the Gold Standard of Scientific Research, and cut the bureaucratic red tape at the Agency to make sure Americans get the Medical Cures and Treatments they deserve.’

Trump made several other announcements Friday evening as he continues his transition, including Dr. Janette Nesheiwat as surgeon general, and Dr. Dave Weldon to head the U.S. Centers for Disease Control and Prevention (CDC). 

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
US scrambles as drones shape the landscape of war: ‘the future is here’
next post
From CDC to labor secretary: See Trump’s top picks for Cabinet roles

Related Posts

President Trump announces multiple judicial nominees, accuses court...

May 8, 2025

HOLLYWOOD ELITES FOR HARRIS: Celebs sign on for...

October 14, 2024

Secret Service admits leaning on ‘state and local...

July 21, 2024

‘Vulnerable’ House lawmakers hold safety summit after Trump...

July 15, 2024

Lawmakers take action after report shows Biden-era SBA...

April 2, 2025

Biden-Harris admin working to ‘Trump-proof’ hundreds of DOJ...

August 29, 2024

Support for Biden impeachment inquiry grows with a...

December 14, 2023

Dems announce 8-figure campaign targeting communities of color...

January 10, 2024

Trump says Biden brought ‘chaos’ to US, vows...

January 11, 2024

Conservatives lash out at Trump after he attacks...

December 20, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • At 90, the Dalai Lama braces for final showdown with Beijing: his reincarnation

      July 4, 2025
    • Russia becomes first nation to recognize Taliban government of Afghanistan since 2021 takeover

      July 4, 2025
    • Two arrested over ‘Chinese blessing scams’ targeting elderly Asian women in Australia

      July 4, 2025
    • Russia launches record number of drones at Ukraine after latest Trump-Putin phone call

      July 4, 2025
    • Elephant kills two female tourists from the UK and New Zealand in Zambian national park

      July 4, 2025
    • What is happening in South Korea? Seoul has caught the lovebug that nobody wants

      July 4, 2025

    Popular

    • 1

      Top 5 Junior Copper Stocks on the TSXV in 2023

      December 22, 2023
    • 2

      Canada Silver Cobalt Begins Drilling at Lowney-Lac Edouard in Quebec, Targeting Nickel-Copper-Cobalt Mineralization

      December 22, 2023
    • 3

      Crypto Market 2023 Year-End Review

      December 22, 2023
    • 4

      10 Top Oil-producing Countries (Updated 2024)

      October 19, 2024
    • 5

      Top 10 Uranium-producing Countries (Updated 2024)

      April 18, 2024
    • 6

      Powered by rain, this seed carrier could help reforest the most remote areas

      December 19, 2023
    • 7

      A troubling theory about traders profiting from Hamas’ attack on Israel drew much attention. Why it may not be so simple.

      December 13, 2023

    Categories

    • Business (1,398)
    • Investing (3,442)
    • Politics (4,517)
    • World (4,416)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: newmarketperspective.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 newmarketperspective.com | All Rights Reserved